The "Rachel Maddow Show" host has slammed the Trump administration's decision to pause communications from America's health ...
Dr. Matthew Memoli, a National Institute of Allergy and Infectious Diseases researcher focused on flu and other respiratory ...
The Supreme Court agreed Friday to decide whether states may reject religious charter schools from receiving public funding, ...
J&J JNJ announced fourth-quarter and full-year 2024 results, starting the earnings season for the drug and biotech sector.
The U.S. Food and Drug Administration has pulled draft guidance from its website requiring companies to test medicines and ...
Federal regulators have warned a Waco company that its human amniotic products are “unlicensed” and “unapproved,” and that ...
At oral arguments earlier this week the Supreme Court was skeptical of the Food and Drug Administration’s effort to block a North Carolina-based company from challenging the denial of its application ...
The FDA has approved GRAFAPEX™ and fludarabine as a preparative regimen in acute myeloid leukemia or myelodysplastic syndrome ...
The Trump administration's "short pause" on communications, expected to end on Feb. 1, has affected FDA updates on food ...
Conservatives are driving a bipartisan push to reform the American diet by imposing new regulations on ultra-processed ...
After a delayed approval, treosulfan’s manufacturer is hopeful the alkylating agent will become the new gold standard in the United States.
The Trump administration’s freeze on communications from U.S. health agencies is leading to another disruption: the abrupt cancellation of scientific meetings. The move covers a swath of health ...